申请人:Achaogen, Inc.
公开号:EP3150617A1
公开(公告)日:2017-04-05
Compounds of structure (I): having antibacterial activity are disclosed, including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein Q1, Q2, Q3, R8 and R9 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
本发明公开了具有抗菌活性的结构(I)化合物,包括其立体异构体、药学上可接受的盐和原药,其中 Q1、Q2、Q3、R8 和 R9 如本文所定义。还公开了与制备和使用此类化合物相关的方法,以及包含此类化合物的药物组合物。